Oyster Point Pharma, Inc. Annual Operating Income (Loss) in USD from 2018 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oyster Point Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2021.
  • Oyster Point Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$33.9M, a 102% decline year-over-year.
  • Oyster Point Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$158M, a 98.2% decline year-over-year.
  • Oyster Point Pharma, Inc. annual Operating Income (Loss) for 2021 was -$96.7M, a 36.2% decline from 2020.
  • Oyster Point Pharma, Inc. annual Operating Income (Loss) for 2020 was -$71M, a 50.1% decline from 2019.
  • Oyster Point Pharma, Inc. annual Operating Income (Loss) for 2019 was -$47.3M, a 183% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$96.7M -$25.7M -36.2% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-24
2020 -$71M -$23.7M -50.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$47.3M -$30.6M -183% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-18
2018 -$16.7M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.